“Health at a Glance: Europe 2024” report by the Organisation for Economic Co-operation and Development (OECD) analyzes critical challenges confronting European health systems

The Organisation for Economic Co-operation and Development (OECD) “Health at a Glance: Europe 2024” report analyzes critical challenges confronting European health systems following the COVID-19 pandemic. Two thematic chapters anchor the publication. The opening chapter delivers an in-depth analysis of Europe’s health workforce crisis. It examines the root causes of personnel shortages and outlines policy […]

“Health at a Glance: Europe 2024” report by the Organisation for Economic Co-operation and Development (OECD) analyzes critical challenges confronting European health systems Read Post »

Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries, Pulmonary Circulation, April 17, 2025

Pulmonary arterial hypertension (PAH) represents a significant economic burden on society, as revealed by a comprehensive Swedish study published on Pulmonary Circulation on April 17, 2025, examining the societal costs associated with this condition. The research tracked patients across various pulmonary arterial hypertension subgroups—idiopathic/hereditary pulmonary arterial hypertension, pulmonary arterial hypertension associated with connective tissue disease,

Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries, Pulmonary Circulation, April 17, 2025 Read Post »

Economic Burden Associated with Pulmonary Arterial Hypertension in the United States, Pharmacoeconomics, October 12, 2024

A study published on Pharmacoeconomics on October 12 reveals that pulmonary arterial hypertension continues to be associated with a very high economic burden and healthcare resource utilization across all payer types within the US healthcare system. The study included 11,670 patients enrolled in Medicare Fee-for-Service, 1,021 patients enrolled in Medicare Advantage, 274 patients enrolled in

Economic Burden Associated with Pulmonary Arterial Hypertension in the United States, Pharmacoeconomics, October 12, 2024 Read Post »

TRANSLATE »
Scroll to Top